ReviewClinical drug investigation2024

Should Glucokinase be Given a Chance in Diabetes Therapeutics? A Clinical-Pharmacological Review of Dorzagliatin and Lessons Learned So Far.

Upinder Kaur et al.PubMed ↗Publisher ↗

No numbers read from the abstract.